Concepedia

Gregory Stoloff

GS

10

Publications

480

Citations

10

H-Index

2007

Active since

Affiliations

Peptcell (United Kingdom)(Current)

National Institute of Allergy and Infectious Diseases

National Institutes of Health

Norwegian Institute of Public Health

University of Groningen

Gregory Stoloff is an author at Peptcell (United Kingdom) specializing in medicine, immunotherapy, and vaccination.

Top concepts

Publications per year

2007–2022

10

Publications

10

Synthetic Influenza vaccine (FLU-v) stimulates cell mediated immunity in a double-blind, randomised, placebo-controlled Phase I trial

Olga Pleguezuelos, Stuart Robinson, Gregory Stoloff et al. · Vaccine · 2012 · 83 citations

, , +13

Synthetic multi‐epitope peptides identified <i>in silico</i> induce protective immunity against multiple influenza serotypes

Gregory Stoloff, Wilson Caparrós‐Wanderley · European Journal of Immunology · 2007 · 82 citations · Full text

Efficacy of FLU-v, a broad-spectrum influenza vaccine, in a randomized phase IIb human influenza challenge study

Olga Pleguezuelos, Emma L. James, Ana M. Fernández et al. · npj Vaccines · 2020 · 78 citations · Full text

A Synthetic Influenza Virus Vaccine Induces a Cellular Immune Response That Correlates with Reduction in Symptomatology and Virus Shedding in a Randomized Phase Ib Live-Virus Challenge in Humans

Olga Pleguezuelos, Stuart Robinson, Ana M. Fernández et al. · Clinical and Vaccine Immunology · 2015 · 60 citations · Full text

Safety and immunogenicity of a mosquito saliva peptide-based vaccine: a randomised, placebo-controlled, double-blind, phase 1 trial

Jessica E. Manning, Fabiano Oliveira, Iliano V. Coutinho-Abreu et al. · The Lancet · 2020 · 57 citations · Full text

, , +7

Rows per page

1–5 of 10